Research study to evaluate the effect of different doses of inhaled glycopyrronium bromide via Nexthaler in COPD patients

Update Il y a 4 ans
Reference: EUCTR2015-000558-40

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective is to identify the optimal dose of CHF 5259 glycopyrronium bromide (GB) to be further developed for the treatment of patients with COPD.


Inclusion criteria

  • Chronic Obstructive Pulmonary Disease (COPD)